GSTM1 and chronic kidney disease: In patients in the CKD-stage-1–3 group, age, male sex (%), and MIS ≥ 8 decreased with increasing BMI; Hb and triglyceride levels and percentage of hypertension and metabolic syndrome increased with increasing BMI.